Cellectis (CLLS) Free Cash Flow (2015 - 2026)
Cellectis' (CLLS) quarterly Free Cash Flow came in at -$15.1 million in Q1 2026, up 9.66% year-on-year from -$13.8 million in Q1 2025, and down 3.73% quarter-over-quarter from -$14.6 million in Q4 2025.
Cellectis (CLLS) Free Cash Flow (2015 - 2026) Analysis & Trends
Cellectis' Free Cash Flow history runs 12 years deep, the most recent figure standing at -$15.1 million for Q1 2026.
- On a quarterly basis, Free Cash Flow rose 9.66% year-over-year to -$15.1 million in Q1 2026; TTM through Mar 2026 was -$40.1 million, a 250.13% decrease from a year earlier, with the FY2025 full-year figure at -$41.8 million, down 304.65% from the prior year.
- Free Cash Flow slipped to -$15.1 million in Q1 2026 per CLLS's latest filing, from -$14.6 million in the prior quarter.
- Across five years, Free Cash Flow topped out at $53.2 million in Q2 2024 and bottomed at -$29.1 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$15.1 million (2026), against an average of -$7.9 million.
- Across the five-year window, Free Cash Flow surged 1677.63% in 2023 and slumped 213.12% in 2025, its largest moves.
- Year by year, Free Cash Flow stood at -$2.2 million in 2022, then jumped by 1677.63% to $34.2 million in 2023, then slumped by 113.63% to -$4.7 million in 2024, then slumped by 213.12% to -$14.6 million in 2025, then declined by 3.73% to -$15.1 million in 2026.
- Per Business Quant, the three latest CLLS Free Cash Flow figures stand at -$15.1 million (Q1 2026), -$14.6 million (Q4 2025), and -$390000.0 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -19.58 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 158.09 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.53 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.29 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 848.30 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -354.95 Mn |
| 10 | Cellectis | 281.48 Mn | 95.81 Mn | - | -15.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -15.15 Mn |
| Mar 31, 2026 | -15.15 Mn |
| Dec 31, 2025 | -14.60 Mn |
| Dec 31, 2025 | -14.60 Mn |
| Sep 30, 2025 | -390,000.00 |
| Sep 30, 2025 | -390,000.00 |
| Jun 30, 2025 | -10.01 Mn |
| Jun 30, 2025 | -10.01 Mn |
| Mar 31, 2025 | -16.77 Mn |
| Mar 31, 2025 | -16.77 Mn |
| Dec 31, 2024 | -4.66 Mn |
| Dec 31, 2024 | -4.66 Mn |
| Sep 30, 2024 | -5.05 Mn |
| Sep 30, 2024 | -5.05 Mn |
| Jun 30, 2024 | 53.22 Mn |
| Jun 30, 2024 | 53.22 Mn |
| Mar 31, 2024 | -23.10 Mn |
| Mar 31, 2024 | -23.10 Mn |
| Dec 31, 2023 | 34.20 Mn |
| Dec 31, 2023 | 34.20 Mn |